Indoleamine-2,3 dioxygenase: a fate-changer of the tumor microenvironment

Area of Science:

• Biochemistry
• Immunology
• Oncology

Background:

• Indoleamine-2,3 dioxygenase (IDO) is a key enzyme in tryptophan catabolism via kynurenine pathways.
• IDO exhibits immunosuppressive properties, aiding cancer cells in immune evasion across various cancer types.
• Elevated IDO production and activity in the tumor microenvironment contribute to anti-tumor immune suppression and promote tumor growth.

Purpose of the Study:

• To provide a focused overview of pathways that enhance indoleamine-2,3 dioxygenase (IDO) activity.
• To highlight the role of IDO in the tumor microenvironment.
• To identify gaps in knowledge and suggest future research directions for IDO function in cancer.

Main Methods:

• Literature review focusing on IDO-enhancing pathways.
• Analysis of molecular and signaling networks involving IDO.
• Synthesis of current understanding of IDO in cancer immunology.

Main Results:

• IDO is upregulated by diverse cytokines and pathways within the tumor microenvironment.
• IDO activity leads to significant anti-tumor immune suppression.
• IDO inhibitors, like 1-methyl-tryptophan, are under investigation in pre-clinical and clinical trials.

Conclusions:

• Understanding IDO-enhancer pathways is crucial for developing effective cancer immunotherapies.
• Further research is needed to fully elucidate the intricate role of IDO in the tumor microenvironment.
• Targeting IDO represents a promising strategy to overcome immune evasion in cancer.